Infertility Treatment Devices and Equipment Market Forecasts to 2028 – Global Analysis By Product Type (Incubators, Sperm Separation Devices, Ovum Aspiration Pumps, Micromanipulator Systems, Sperm Analyzer Systems, Gas Analyzers, Laser Systems, Cryosystem

Infertility Treatment Devices and Equipment Market Forecasts to 2028 – Global Analysis By Product Type (Incubators, Sperm Separation Devices, Ovum Aspiration Pumps, Micromanipulator Systems, Sperm Analyzer Systems, Gas Analyzers, Laser Systems, Cryosystems and Other Product Types), Procedure, End User and By Geography

According to Stratistics MRC, the Global Infertility Treatment Devices and Equipment Market is accounted for $1.6 billion in 2022 and is expected to reach $2.9 billion by 2028 growing at a CAGR of 10.4% during the forecast period. Infertility is the inability to conceive or become pregnant. Primary infertility is a possibility. Patients have access to a wide range of technology and devices for treating infertility. Since there is a low fertility rate, there will be an increase in people seeking infertility therapy during the next few years. Numerous businesses have created unique tools and techniques for quick, efficient, and affordable reproductive treatments.

According to the United Nations, the global fertility rate is expected to fall to 2.4 births per woman by 2030 and 2.2 births per woman by 2050 (UN). Currently, 46% of the world's population resides in countries with low fertility rates. Another 46% of the population lives in nations with intermediate fertility, and the last 8% lives in high fertility countries.

Market Dynamics

Driver

Improvements in assisted reproductive treatments

One of the most advanced infertility treatments is time-lapse imaging. Without disrupting the culture, time-lapse imaging can be used to periodically monitor the embryonic growth process. Every day, embryos would be removed from the incubator for monitoring procedures to examine them. Due to advancements in technology and the use of computers, embryos can continue to grow in the incubator without being interrupted. Consequently, this is the main driver causing the industry to rise.

Restraint

Multiplicity and risk of preterm delivery

When more than one foetus is transplanted into the mother's uterus during IVF infertility therapy, multiple pregnancies are more likely, and if the infants are multiple, the risk of preterm delivery is increased. IVF-created embryos are born early and have smaller weights than typical embryos. Ovarian hyper stimulation syndrome symptoms include rapid weight gain and shortness of breath. Therefore, this is the main factor hindering market growth.

Opportunity

Declining fertility rate

Due to a variety of circumstances, including the rising trend of late marriages and the rise in age-related infertility, the fertility rate globally is progressively dropping. An individual's inability to develop a healthy clinical pregnancy is referred to as infertility. The demand for infertility treatment goods has significantly increased as a result of the dropping fertility rate. A number of factors, such as a rise in late marriages and an increase in age-related infertility, are contributing to the gradual decline in the global fertility rate.

Threat

High costs associated with assisted reproductive technology

Thousands of cycles of ART procedures including in vitro fertilisation (IVF) are carried out each year in addition to fertility surgery. Due to the absence of reimbursement policies, the cost of IVF therapy varies from nation to nation. Strict government rules, a shortage of competent staff, rising treatment prices, and expensive infertility treatment technologies are a few of the issues impeding the market's expansion.

Covid-19 Impact

The expansion of the COVID-19 is in decline due to the major difficulties that patients and professional healthcare practitioners are experiencing. Organising logistics, prioritising patients and conditions, treating sick patients, and shielding medical staff and other front-line workers from the virus are just a few of the significant difficulties. The Pandemic had a negative effect on the market for infertility treatment devices due to the declining effect on businesses, patient disease management, logistical issues, prioritising patients, and the critical need to protect the general public and hospital frontline staff from virus exposure.

The sperm separation devices segment is expected to be the largest during the forecast period

The sperm separation devices segment is estimated to have a lucrative growth, due to they are used in assisted reproductive treatments. Additionally, these devices have a shorter shelf life than other types of capital equipment like incubators. To ensure maximum productivity, this equipment must be replaced in a few years. Devices for sperm separation can isolate highly mobile sperms with strong DNA integrity from a semen sample.

The fertility clinics segment is expected to have the highest CAGR during the forecast period

The fertility clinics segment is anticipated to witness the fastest CAGR growth during the forecast period, due to offer couples counselling and treatment plans based on the severity and causes of their infertility. At accredited fertility clinics, all forms of infertility treatment treatments are carried out. Before beginning the treatment processes, consultation is required, during which the causes of infertility are determined. In order to improve the likelihood of pregnancy, fertility doctors can also recommend fertility medicines.

Region with Largest share

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rise in fertility tourism, an increase in the number of international players focusing on entering the market in economically developing countries, and changing regulatory landscape. It raises awareness of ART & infertility and improves the availability of infertility-related services in the area. It is also predicted that increasing government efforts to improve access to infertility treatment will accelerate market expansion in the region.

Region with highest CAGR

Europe is projected to have the highest CAGR over the forecast period, owing to the increasing number of market players and the launch of new products. The region's market is expected to increase as a result of the introduction of cutting-edge technologies, which offer enormous growth opportunities for hospitals, equipment manufacturers, and fertility clinics.

Key players in the market

Some of the key players profiled in the Infertility Treatment Devices and Equipment Market include Thermo Fisher Scientific, Genea Biomedx Ltd., Esco Micro Pte Ltd., FUJIFILM Irvine Scientific, The Baker Company INC., AB Scientific Ltd, The Cooper Companies Inc., Hamilton Thorne, Inc, Cook Medical, Vitrolife, Art Biotech Pvt. Ltd., Irvine Scientific, Dxnow, Inc., LabIVF Asia Pte Ltd., Rocket Medical plc and Microptic.

Key Developments

In February 2022, Cooper Companies Inc., a medical device company, announced that had signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets.

In February 2021, CooperSurgical announced a partnership with Virtus Health to strengthen its fertility technology, increasing the accessibility of advanced treatment to infertile couples.

Product Types Covered
• Incubators
• Sperm Separation Devices
• Ovum Aspiration Pumps
• Micromanipulator Systems
• Sperm Analyzer Systems
• Gas Analyzers
• Laser Systems
• Cryosystems
• Other Product Types

Procedures Covered
• Artificial Insemination
• Assisted Reproductive Technology
• Fertility Surgery
• Other Procedures

End Users Covered
• Clinical Research Institutes
• Hospitals
• Fertility Clinics
• Other End Users

Regions Covered
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities,Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements